Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 USD | +0.22% | -1.86% | +3.73% |
May. 09 | Medincell: share price rises on resumption of trading | CF |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.73% | 283B | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B | |
-2.71% | 160B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Receives Option to License Worldwide Rights to Cugene's CUG252 for Autoimmune, Inflammatory Diseases